Global Pneumococcal Vaccine Polyvalent Supply, Demand and Key Producers, 2023-2029

Page: 80

Published Date: 26 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Pneumococcal Vaccine Polyvalent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.

This report studies the global Pneumococcal Vaccine Polyvalent production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pneumococcal Vaccine Polyvalent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pneumococcal Vaccine Polyvalent that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pneumococcal Vaccine Polyvalent total production and demand, 2018-2029, (K Units)
Global Pneumococcal Vaccine Polyvalent total production value, 2018-2029, (USD Million)
Global Pneumococcal Vaccine Polyvalent production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pneumococcal Vaccine Polyvalent consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pneumococcal Vaccine Polyvalent domestic production, consumption, key domestic manufacturers and share
Global Pneumococcal Vaccine Polyvalent production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pneumococcal Vaccine Polyvalent production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pneumococcal Vaccine Polyvalent production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Pneumococcal Vaccine Polyvalent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co. and Pfizer etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pneumococcal Vaccine Polyvalent market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pneumococcal Vaccine Polyvalent Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pneumococcal Vaccine Polyvalent Market, Segmentation by Type
Prevnar 13
Pneumovax23

Global Pneumococcal Vaccine Polyvalent Market, Segmentation by Application
18 Years and Younger
19 To 64 Years Old
65 Years and Older

Companies Profiled:
Merck & Co.
Pfizer

Key Questions Answered
1. How big is the global Pneumococcal Vaccine Polyvalent market?
2. What is the demand of the global Pneumococcal Vaccine Polyvalent market?
3. What is the year over year growth of the global Pneumococcal Vaccine Polyvalent market?
4. What is the production and production value of the global Pneumococcal Vaccine Polyvalent market?
5. Who are the key producers in the global Pneumococcal Vaccine Polyvalent market?

Table of Contents

1 Supply Summary
    1.1 Pneumococcal Vaccine Polyvalent Introduction
    1.2 World Pneumococcal Vaccine Polyvalent Supply & Forecast
        1.2.1 World Pneumococcal Vaccine Polyvalent Production Value (2018 & 2022 & 2029)
        1.2.2 World Pneumococcal Vaccine Polyvalent Production (2018-2029)
        1.2.3 World Pneumococcal Vaccine Polyvalent Pricing Trends (2018-2029)
    1.3 World Pneumococcal Vaccine Polyvalent Production by Region (Based on Production Site)
        1.3.1 World Pneumococcal Vaccine Polyvalent Production Value by Region (2018-2029)
        1.3.2 World Pneumococcal Vaccine Polyvalent Production by Region (2018-2029)
        1.3.3 World Pneumococcal Vaccine Polyvalent Average Price by Region (2018-2029)
        1.3.4 North America Pneumococcal Vaccine Polyvalent Production (2018-2029)
        1.3.5 Europe Pneumococcal Vaccine Polyvalent Production (2018-2029)
        1.3.6 China Pneumococcal Vaccine Polyvalent Production (2018-2029)
        1.3.7 Japan Pneumococcal Vaccine Polyvalent Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pneumococcal Vaccine Polyvalent Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pneumococcal Vaccine Polyvalent Major Market Trends

2 Demand Summary
    2.1 World Pneumococcal Vaccine Polyvalent Demand (2018-2029)
    2.2 World Pneumococcal Vaccine Polyvalent Consumption by Region
        2.2.1 World Pneumococcal Vaccine Polyvalent Consumption by Region (2018-2023)
        2.2.2 World Pneumococcal Vaccine Polyvalent Consumption Forecast by Region (2024-2029)
    2.3 United States Pneumococcal Vaccine Polyvalent Consumption (2018-2029)
    2.4 China Pneumococcal Vaccine Polyvalent Consumption (2018-2029)
    2.5 Europe Pneumococcal Vaccine Polyvalent Consumption (2018-2029)
    2.6 Japan Pneumococcal Vaccine Polyvalent Consumption (2018-2029)
    2.7 South Korea Pneumococcal Vaccine Polyvalent Consumption (2018-2029)
    2.8 ASEAN Pneumococcal Vaccine Polyvalent Consumption (2018-2029)
    2.9 India Pneumococcal Vaccine Polyvalent Consumption (2018-2029)

3 World Pneumococcal Vaccine Polyvalent Manufacturers Competitive Analysis
    3.1 World Pneumococcal Vaccine Polyvalent Production Value by Manufacturer (2018-2023)
    3.2 World Pneumococcal Vaccine Polyvalent Production by Manufacturer (2018-2023)
    3.3 World Pneumococcal Vaccine Polyvalent Average Price by Manufacturer (2018-2023)
    3.4 Pneumococcal Vaccine Polyvalent Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Pneumococcal Vaccine Polyvalent Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Pneumococcal Vaccine Polyvalent in 2022
        3.5.3 Global Concentration Ratios (CR8) for Pneumococcal Vaccine Polyvalent in 2022
    3.6 Pneumococcal Vaccine Polyvalent Market: Overall Company Footprint Analysis
        3.6.1 Pneumococcal Vaccine Polyvalent Market: Region Footprint
        3.6.2 Pneumococcal Vaccine Polyvalent Market: Company Product Type Footprint
        3.6.3 Pneumococcal Vaccine Polyvalent Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Pneumococcal Vaccine Polyvalent Production Value Comparison
        4.1.1 United States VS China: Pneumococcal Vaccine Polyvalent Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Pneumococcal Vaccine Polyvalent Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Pneumococcal Vaccine Polyvalent Production Comparison
        4.2.1 United States VS China: Pneumococcal Vaccine Polyvalent Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Pneumococcal Vaccine Polyvalent Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Pneumococcal Vaccine Polyvalent Consumption Comparison
        4.3.1 United States VS China: Pneumococcal Vaccine Polyvalent Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Pneumococcal Vaccine Polyvalent Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Pneumococcal Vaccine Polyvalent Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Pneumococcal Vaccine Polyvalent Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production (2018-2023)
    4.5 China Based Pneumococcal Vaccine Polyvalent Manufacturers and Market Share
        4.5.1 China Based Pneumococcal Vaccine Polyvalent Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value (2018-2023)
        4.5.3 China Based Manufacturers Pneumococcal Vaccine Polyvalent Production (2018-2023)
    4.6 Rest of World Based Pneumococcal Vaccine Polyvalent Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Pneumococcal Vaccine Polyvalent Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production (2018-2023)

5 Market Analysis by Type
    5.1 World Pneumococcal Vaccine Polyvalent Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Prevnar 13
        5.2.2 Pneumovax23
    5.3 Market Segment by Type
        5.3.1 World Pneumococcal Vaccine Polyvalent Production by Type (2018-2029)
        5.3.2 World Pneumococcal Vaccine Polyvalent Production Value by Type (2018-2029)
        5.3.3 World Pneumococcal Vaccine Polyvalent Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Pneumococcal Vaccine Polyvalent Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 18 Years and Younger
        6.2.2 19 To 64 Years Old
        6.2.3 65 Years and Older
    6.3 Market Segment by Application
        6.3.1 World Pneumococcal Vaccine Polyvalent Production by Application (2018-2029)
        6.3.2 World Pneumococcal Vaccine Polyvalent Production Value by Application (2018-2029)
        6.3.3 World Pneumococcal Vaccine Polyvalent Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Merck & Co.
        7.1.1 Merck & Co. Details
        7.1.2 Merck & Co. Major Business
        7.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
        7.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Merck & Co. Recent Developments/Updates
        7.1.6 Merck & Co. Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Pneumococcal Vaccine Polyvalent Product and Services
        7.2.4 Pfizer Pneumococcal Vaccine Polyvalent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pneumococcal Vaccine Polyvalent Industry Chain
    8.2 Pneumococcal Vaccine Polyvalent Upstream Analysis
        8.2.1 Pneumococcal Vaccine Polyvalent Core Raw Materials
        8.2.2 Main Manufacturers of Pneumococcal Vaccine Polyvalent Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Pneumococcal Vaccine Polyvalent Production Mode
    8.6 Pneumococcal Vaccine Polyvalent Procurement Model
    8.7 Pneumococcal Vaccine Polyvalent Industry Sales Model and Sales Channels
        8.7.1 Pneumococcal Vaccine Polyvalent Sales Model
        8.7.2 Pneumococcal Vaccine Polyvalent Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pneumococcal Vaccine Polyvalent Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Pneumococcal Vaccine Polyvalent Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Pneumococcal Vaccine Polyvalent Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Region (2018-2023)
    Table 5. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Region (2024-2029)
    Table 6. World Pneumococcal Vaccine Polyvalent Production by Region (2018-2023) & (K Units)
    Table 7. World Pneumococcal Vaccine Polyvalent Production by Region (2024-2029) & (K Units)
    Table 8. World Pneumococcal Vaccine Polyvalent Production Market Share by Region (2018-2023)
    Table 9. World Pneumococcal Vaccine Polyvalent Production Market Share by Region (2024-2029)
    Table 10. World Pneumococcal Vaccine Polyvalent Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Pneumococcal Vaccine Polyvalent Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Pneumococcal Vaccine Polyvalent Major Market Trends
    Table 13. World Pneumococcal Vaccine Polyvalent Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Pneumococcal Vaccine Polyvalent Consumption by Region (2018-2023) & (K Units)
    Table 15. World Pneumococcal Vaccine Polyvalent Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Pneumococcal Vaccine Polyvalent Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Pneumococcal Vaccine Polyvalent Producers in 2022
    Table 18. World Pneumococcal Vaccine Polyvalent Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Pneumococcal Vaccine Polyvalent Producers in 2022
    Table 20. World Pneumococcal Vaccine Polyvalent Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Pneumococcal Vaccine Polyvalent Company Evaluation Quadrant
    Table 22. World Pneumococcal Vaccine Polyvalent Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Pneumococcal Vaccine Polyvalent Production Site of Key Manufacturer
    Table 24. Pneumococcal Vaccine Polyvalent Market: Company Product Type Footprint
    Table 25. Pneumococcal Vaccine Polyvalent Market: Company Product Application Footprint
    Table 26. Pneumococcal Vaccine Polyvalent Competitive Factors
    Table 27. Pneumococcal Vaccine Polyvalent New Entrant and Capacity Expansion Plans
    Table 28. Pneumococcal Vaccine Polyvalent Mergers & Acquisitions Activity
    Table 29. United States VS China Pneumococcal Vaccine Polyvalent Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Pneumococcal Vaccine Polyvalent Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Pneumococcal Vaccine Polyvalent Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Pneumococcal Vaccine Polyvalent Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production Market Share (2018-2023)
    Table 37. China Based Pneumococcal Vaccine Polyvalent Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Pneumococcal Vaccine Polyvalent Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Pneumococcal Vaccine Polyvalent Production Market Share (2018-2023)
    Table 42. Rest of World Based Pneumococcal Vaccine Polyvalent Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production Market Share (2018-2023)
    Table 47. World Pneumococcal Vaccine Polyvalent Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Pneumococcal Vaccine Polyvalent Production by Type (2018-2023) & (K Units)
    Table 49. World Pneumococcal Vaccine Polyvalent Production by Type (2024-2029) & (K Units)
    Table 50. World Pneumococcal Vaccine Polyvalent Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Pneumococcal Vaccine Polyvalent Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Pneumococcal Vaccine Polyvalent Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Pneumococcal Vaccine Polyvalent Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Pneumococcal Vaccine Polyvalent Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Pneumococcal Vaccine Polyvalent Production by Application (2018-2023) & (K Units)
    Table 56. World Pneumococcal Vaccine Polyvalent Production by Application (2024-2029) & (K Units)
    Table 57. World Pneumococcal Vaccine Polyvalent Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Pneumococcal Vaccine Polyvalent Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Pneumococcal Vaccine Polyvalent Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Pneumococcal Vaccine Polyvalent Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 62. Merck & Co. Major Business
    Table 63. Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
    Table 64. Merck & Co. Pneumococcal Vaccine Polyvalent Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Merck & Co. Recent Developments/Updates
    Table 66. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 67. Pfizer Major Business
    Table 68. Pfizer Pneumococcal Vaccine Polyvalent Product and Services
    Table 69. Pfizer Pneumococcal Vaccine Polyvalent Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 70. Global Key Players of Pneumococcal Vaccine Polyvalent Upstream (Raw Materials)
    Table 71. Pneumococcal Vaccine Polyvalent Typical Customers
    Table 72. Pneumococcal Vaccine Polyvalent Typical Distributors
List of Figure
    Figure 1. Pneumococcal Vaccine Polyvalent Picture
    Figure 2. World Pneumococcal Vaccine Polyvalent Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Pneumococcal Vaccine Polyvalent Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Pneumococcal Vaccine Polyvalent Production (2018-2029) & (K Units)
    Figure 5. World Pneumococcal Vaccine Polyvalent Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Region (2018-2029)
    Figure 7. World Pneumococcal Vaccine Polyvalent Production Market Share by Region (2018-2029)
    Figure 8. North America Pneumococcal Vaccine Polyvalent Production (2018-2029) & (K Units)
    Figure 9. Europe Pneumococcal Vaccine Polyvalent Production (2018-2029) & (K Units)
    Figure 10. China Pneumococcal Vaccine Polyvalent Production (2018-2029) & (K Units)
    Figure 11. Japan Pneumococcal Vaccine Polyvalent Production (2018-2029) & (K Units)
    Figure 12. Pneumococcal Vaccine Polyvalent Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 15. World Pneumococcal Vaccine Polyvalent Consumption Market Share by Region (2018-2029)
    Figure 16. United States Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 17. China Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 18. Europe Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 19. Japan Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 22. India Pneumococcal Vaccine Polyvalent Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Pneumococcal Vaccine Polyvalent by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Pneumococcal Vaccine Polyvalent Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Pneumococcal Vaccine Polyvalent Markets in 2022
    Figure 26. United States VS China: Pneumococcal Vaccine Polyvalent Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Pneumococcal Vaccine Polyvalent Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Pneumococcal Vaccine Polyvalent Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Pneumococcal Vaccine Polyvalent Production Market Share 2022
    Figure 30. China Based Manufacturers Pneumococcal Vaccine Polyvalent Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Pneumococcal Vaccine Polyvalent Production Market Share 2022
    Figure 32. World Pneumococcal Vaccine Polyvalent Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Type in 2022
    Figure 34. Prevnar 13
    Figure 35. Pneumovax23
    Figure 36. World Pneumococcal Vaccine Polyvalent Production Market Share by Type (2018-2029)
    Figure 37. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Type (2018-2029)
    Figure 38. World Pneumococcal Vaccine Polyvalent Average Price by Type (2018-2029) & (USD/Unit)
    Figure 39. World Pneumococcal Vaccine Polyvalent Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Application in 2022
    Figure 41. 18 Years and Younger
    Figure 42. 19 To 64 Years Old
    Figure 43. 65 Years and Older
    Figure 44. World Pneumococcal Vaccine Polyvalent Production Market Share by Application (2018-2029)
    Figure 45. World Pneumococcal Vaccine Polyvalent Production Value Market Share by Application (2018-2029)
    Figure 46. World Pneumococcal Vaccine Polyvalent Average Price by Application (2018-2029) & (USD/Unit)
    Figure 47. Pneumococcal Vaccine Polyvalent Industry Chain
    Figure 48. Pneumococcal Vaccine Polyvalent Procurement Model
    Figure 49. Pneumococcal Vaccine Polyvalent Sales Model
    Figure 50. Pneumococcal Vaccine Polyvalent Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck & Co.
Pfizer

Related Reports

Global Pneumococcal Vaccine Polyvalent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pneumococcal Vaccine Polyvalent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 26 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pneumococcal Vaccine Polyvalent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Pneumococcal Vaccine Polyvalent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pneumococcal Vaccine Polyvalent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pneumococcal Vaccine Polyvalent market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Pneumococcal Vaccine Polyvalent Supply, Demand and Key Producers, 2024-2030

Global Pneumococcal Vaccine Polyvalent Supply, Demand and Key Producers, 2024-2030

date 08 Feb 2024

date Pharma & Healthcare

The global Pneumococcal Vaccine Polyvalent market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Pneumococcal Vaccine Polyvalent

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>